<DOC>
	<DOCNO>NCT01223625</DOCNO>
	<brief_summary>The aim study measure effect moderate intensive lipid-lowering treatment rosuvastatin endothelial function .</brief_summary>
	<brief_title>Effect Intensive Lipid Lowering Treatment Compared Moderate Lipid Lowering Treatment Endothelial Function</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . STEMI 2. prior treatment statins 1. age 18 81 year 2. unconscious patient 3. serum creatinine &gt; 176Î¼mol/L 4. totalcholesterol &gt; 7.0 mmol/l 5. hypothyreoidism ( ( TSH &gt; 1.5 x ULN ( upper limit normal ) ) 6. current liver disease ( ALAT &gt; 2 x ULN ) 7. unexplained creatine kinase &gt; 3 x ULN 8. alcohol drug abuse within last five year 9. prior myopathy serious hypersensitivity reaction cause statin 10. woman childbearing potential use chemical mechanical contraception 11. pregnant breastfeed woman 12. history malignancy unless diseasefree period five year present 13. patient abnormal lung function test ( LFT ) 14. participation another investigational drug study less four week enrolment present study 15. treatment cyclosporine fibrates .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>